1-3 of 3
Pina M. Cardarelli
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 732: Toward optimizing CXCR4 inhibition with beta adrenergic blockade to enhance chemotherapy response in acute myeloid leukemia

Brenda Loera, Chunxiao Zhang, Pina M. Cardarelli, Niña G. Caculitan, Sylvia Chien, Jin Dai, Vivian G. Oehler, Jianying Zhang, Guido Marcucci, Pamela S. Becker
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 732.
https://doi.org/10.1158/1538-7445.AM2024-732
Published: 22 March 2024
View article titled, Abstract 732: Toward optimizing CXCR4 inhibition with beta adrenergic blockade to enhance chemotherapy response in acute myeloid leukemia
Journal Articles

Abstract 2446: Biodistribution of antibody drug conjugates by LC-MS

Mohan Srinivasan, Lourdes Thevanayagam, Indrani Chakraborty, Alasdair Bell, Shrikant Deshpande, Chin Pan, Pina M. Cardarelli, Sanjeev Gangwar, Colin Chong, Orville Cortez, David Klitzing, Jerry Jiang, Meghan Greenbaum, James Phillips
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 2446.
https://doi.org/10.1158/1538-7445.AM10-2446
Published: 15 April 2010
View article titled, Abstract 2446: Biodistribution of antibody drug conjugates by LC-MS
Journal Articles

CD10 Is a Key Enzyme Involved in the Activation of Tumor-activated Peptide Prodrug CPI-0004Na and Novel Analogues: Implications for the Design of Novel Peptide Prodrugs for the Therapy of CD10+ Tumors

Chin Pan, Pina M. Cardarelli, Matthew H. Nieder, Lesley B. Pickford, Sanjeev Gangwar, David J. King, Geoffrey T. Yarranton, Dana Buckman, William Roscoe, Fengmin Zhou, Adam Salles, Tseng-Hui Chen, Killian Horgan, Yi-Hong Wang, Thi Nguyen, Christopher R. Bebbington
Journal: Cancer Research
Cancer Res (2003) 63 (17): 5526–5531.
Published: 18 September 2003
View article titled, CD10 Is a Key Enzyme Involved in the Activation of Tumor-activated Peptide Prodrug CPI-0004Na and Novel Analogues: Implications for the Design of Novel Peptide Prodrugs for the Therapy of CD10<sup>+</sup> Tumors
Open the PDF for CD10 Is a Key Enzyme Involved in the Activation of Tumor-activated Peptide Prodrug CPI-0004Na and Novel Analogues: Implications for the Design of Novel Peptide Prodrugs for the Therapy of CD10<sup>+</sup> Tumors in another window